Target intelligence / Profile preview

Cardiac ion channel modulation

Molecular classification
Ion channel, Voltage-gated ion channel, Ligand-gated ion channel (in some cardiac contexts), Calcium-activated channel, Mechanosensitive channel
01

Overview

Cardiac ion channels are membrane-embedded proteins critical for the generation and propagation of electrical impulses in the heart. These include multiple families—voltage-gated sodium, calcium, and potassium channels—and are responsible for the phases of the cardiac action potential. Modulation of these channels, whether by drugs or endogenous factors, offers a vital therapeutic approach in treating cardiac arrhythmias, hypertension, and other heart diseases, but requires careful balance due to the risk of adverse events such as proarrhythmia. Instead of representing a single molecular target, "cardiac ion channel modulation" encompasses modulation of several distinct ion channel types, each with specific molecular identity and therapeutic relevance.

Other names
Cardiac ion channelscardiac sodium channelcardiac potassium channelcardiac calcium channel
02

Mechanism of action

Channel blockade (inhibition of ion flux); Channel activation (facilitation of ion flux); Channel modulation (change gating properties, e.g., prolongation/reduction of action potential duration); Altered channel expression or trafficking; Allosteric modulation (affecting associated proteins)

03

Biological functions

Electrical signal conductionAction potential generationExcitation–contraction couplingRegulation of cardiac rhythmMembrane potential stabilization
04

Disease associations

ArrhythmiaHeart failureHypertensionCardiovascular diseaseAutoimmunity (via ion channel autoantibodies)Some genetic syndromes (e.g., Long QT syndrome, Brugada syndrome, channelopathies)
05

Safety considerations

Proarrhythmia (drug-induced arrhythmia, e.g., Torsades de Pointes)QT prolongation, sudden cardiac deathPotential impact on non-cardiac tissues (off-target effects)Narrow therapeutic window for some agentsDrug-drug interactions affecting channel blockers
06

Interacting drugs

Amiodarone (potassium/sodium channel blocker)

6 more in the full profile.

07

Biomarkers

Electrocardiogram (ECG) parameters (QT interval, QRS duration)Plasma electrolytes (e.g., potassium, calcium, sodium)Genetic markers for channelopathies (KCNA5, SCN5A, KCNH2, etc.)

Beyond the preview

Go deeper on Cardiac ion channel modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac ion channel modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call